Showing results (1641-1650 of 1,908) with videos related to

Sort By:
Pageof 191
The Journal of Emergency Medicine|June 24, 2023
OUTCOMES OF MISSED DIAGNOSIS OF PEDIATRIC APPENDICITIS, NEW-ONSET DIABETIC KETOACIDOSIS, AND SEPSIS IN FIVE PEDIATRIC HOSPITALSKenneth A Michelson, Richard G Bachur, Joseph A Grubenhoff, et al.
Annals of Emergency Medicine|August 8, 2022
Prevalence and Management of Invasive Bacterial Infections in Febrile Infants Ages 2 to 6 MonthsRebecca S Green, Laura F Sartori, Brian E Lee, et al.
Open Forum Infectious Diseases|January 8, 2026
Characteristics and Outcomes of Patients With Hematologic Malignancies Hospitalized With Respiratory Viral InfectionsZulfiqar A Lokhandwala, Brenna Park-Egan, Ravneet Waraich, et al.
European Journal of Heart Failure|February 24, 2007
Prevalence and prognostic impact of bundle branch block in patients with heart failure: evidence from the CHARM programmeNathaniel M Hawkins, Duolao Wang, John J V McMurray, et al.
Heart (British Cardiac Society)|September 6, 2006
Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programmeN M Hawkins, D Wang, J J V McMurray, et al.
The Journal of Pediatrics|April 7, 2005
Patterns of brain injury in term neonatal encephalopathySteven P Miller, Vijay Ramaswamy, David Michelson, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|September 15, 2020
Does the first hour of continuous electroencephalography predict neonatal seizures?Emma Macdonald-Laurs, Cynthia Sharpe, Mark Nespeca, et al.
Alzheimer'S Research & Therapy|August 8, 2019
Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer's diseaseMichael F Egan, Yuki Mukai, Tiffini Voss, et al.
BMJ Open|February 9, 2020
Randomised feasibility trial of the helping families programme-modified: an intensive parenting intervention for parents affected by severe personality difficultiesCrispin Day, Jackie Briskman, Mike J Crawford, et al.
American Heart Journal|April 29, 2006
Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trialJohn J V McMurray, James B Young, Mark E Dunlap, et al.
Pageof 191